East Greenbush, NY, United States of America

Phillip M John

This inventor holds 3 USPTO granted patents. Top assignee: Sterling Drug Inc.. Active years: 1978-1983.


% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 109(Granted Patents)


Company Filing History:


Years Active: 1978-1983

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Phillip M John

Introduction

Phillip M John is a notable inventor based in East Greenbush, NY (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing innovative drug formulations that enhance patient experience and medication efficacy.

Latest Patents

Among his latest patents, Phillip M John has developed a sustained-release pharmaceutical tablet and a process for its preparation. This invention consists of drug pellets encapsulated with both a water-soluble and a water-insoluble film-forming substance, which are blended and compressed into tablet form. Another significant patent is for an easily-swallowed, powder-free, gastric-disintegrable aspirin tablet. This method allows for the preparation of an aspirin tablet that is thinly coated to mask the characteristic taste and reduce esophageal discomfort, while ensuring it disintegrates in the stomach at a rate comparable to uncoated tablets.

Career Highlights

Phillip M John is currently associated with Sterling Drug Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in improving the delivery and effectiveness of medications, making them more accessible and easier to consume for patients.

Collaborations

Throughout his career, Phillip has collaborated with notable colleagues such as Raymond J Belanger and Myron Paikoff. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Phillip M John exemplifies the spirit of innovation in the pharmaceutical industry. His patents reflect a commitment to improving patient care through effective drug formulations. His contributions continue to influence the field and enhance the quality of life for many individuals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…